1-4 of 4
Hendrik Veelken
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-012: Autonomous, antigen-independent B-cell receptor signalling as a novel pathogenetic mechanism in non-GCB DLBCL

Marvyn T. Koning, Rudolf Übelhart, Arjen H.G. Cleven, Willem H. Zoutman, Sander A.J. van der Zeeuw, Philip Kluin, Marieke Griffioen, Hans G. Drexler, Cornelis P. Tensen, Maarten H. Vermeer, Rein Willemze, Szymon M. Kielbasa, Marcelo A. Navarrete, Hassan Jumaa, Hendrik Veelken
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-012.
https://doi.org/10.1158/1538-7445.AM2016-LB-012
Published: 15 July 2016
View article titled, Abstract LB-012: Autonomous, antigen-independent B-cell receptor signalling as a novel pathogenetic mechanism in non-GCB DLBCL
Journal Articles

The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease

Christine Dierks, Francisco Adrian, Paul Fisch, Hong Ma, Helga Maurer, Dieter Herchenbach, Christine Ulrike Forster, Clara Sprissler, Guoxun Liu, Sabine Rottmann, Gui-Rong Guo, Zirlik Katja, Hendrik Veelken, Markus Warmuth
Journal: Cancer Research
Cancer Res (2010) 70 (15): 6193–6204.
https://doi.org/10.1158/0008-5472.CAN-08-3719
Published: 28 July 2010
View article titled, The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease
Open the PDF for The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease in another window
Includes: Supplementary data
Journal Articles

Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia

Maike Buchner, Simon Fuchs, Gabriele Prinz, Dietmar Pfeifer, Kilian Bartholomé, Meike Burger, Nina Chevalier, Laurent Vallat, Jens Timmer, John G. Gribben, Hassan Jumaa, Hendrik Veelken, Christine Dierks, Katja Zirlik
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5424–5432.
https://doi.org/10.1158/0008-5472.CAN-08-4252
Published: 01 July 2009
View article titled, Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
Open the PDF for Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia in another window
Journal Articles

Phase I Trial of a Novel Intradermal Idiotype Vaccine in Patients with Advanced B-Cell Lymphoma: Specific Immune Responses Despite Profound Immunosuppression

Cristina Bertinetti, Katja Zirlik, Kristina Heining-Mikesch, Gabriele Ihorst, Heide Dierbach, Cornelius F. Waller, Hendrik Veelken
Journal: Cancer Research
Cancer Res (2006) 66 (8): 4496–4502.
https://doi.org/10.1158/0008-5472.CAN-05-4233
Published: 17 April 2006
View article titled, Phase I Trial of a Novel Intradermal Idiotype Vaccine in Patients with Advanced B-Cell Lymphoma: Specific Immune Responses Despite Profound Immunosuppression
Open the PDF for Phase I Trial of a Novel Intradermal Idiotype Vaccine in Patients with Advanced B-Cell Lymphoma: Specific Immune Responses Despite Profound Immunosuppression in another window